| Literature DB >> 32526197 |
Hyun-Sik Yang1, Charles C White2, Hans-Ulrich Klein2, Lei Yu3, Christopher Gaiteri3, Yiyi Ma2, Daniel Felsky2, Sara Mostafavi4, Vladislav A Petyuk5, Reisa A Sperling6, Nilüfer Ertekin-Taner7, Julie A Schneider3, David A Bennett3, Philip L De Jager8.
Abstract
Here, we perform a genome-wide screen for variants that regulate the expression of gene co-expression modules in the aging human brain; we discover and replicate such variants in the TMEM106B and RBFOX1 loci. The TMEM106B haplotype is known to influence the accumulation of TAR DNA-binding protein 43 kDa (TDP-43) proteinopathy, and the haplotype's large-scale transcriptomic effects include the dysregulation of lysosomal genes and alterations in synaptic gene splicing that are also seen in the pathophysiology of TDP-43 proteinopathy. Further, a variant near GRN, another TDP-43 proteinopathy susceptibility gene, shows concordant effects with the TMEM106B haplotype. Leveraging neuropathology data from the same participants, we also show that TMEM106B and APOE-amyloid-β effects converge to alter myelination and lysosomal gene expression, which then contributes to TDP-43 accumulation. These results advance our mechanistic understanding of the TMEM106B TDP-43 risk haplotype and uncover a transcriptional program that mediates the converging effects of APOE-amyloid-β and TMEM106B on TDP-43 aggregation in older adults.Entities:
Keywords: Alzheimer's disease; Amyloid-β; GRN; RBFOX1; TDP-43; TMEM106B; co-expression module; cognitive resilience; eQTL; expression quantitative trait loci; sQTL; splicing quantitative trait loci
Mesh:
Substances:
Year: 2020 PMID: 32526197 PMCID: PMC7416464 DOI: 10.1016/j.neuron.2020.05.010
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173